Skip to main content
Viewing from:
Department GEZ-LTA Erasmushogeschool
Intended for healthcare professionals
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via CCMG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Topic collections
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Topic collections
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via CCMG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
More
You are viewing from:
Department GEZ-LTA Erasmushogeschool
You are here
Home
Archive
Volume 56, Issue 1
Applications and advances of CRISPR-Cas9 in cancer immunotherapy
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Methods
Review
Applications and advances of CRISPR-Cas9 in cancer immunotherapy
Online download statistics by month:
Online download statistics by month: July 2018 to April 2025
Abstract
Full
Pdf
Jul 2018
1337
163
110
Aug 2018
892
78
28
Sep 2018
757
55
24
Oct 2018
1437
380
134
Nov 2018
1687
112
44
Dec 2018
2130
117
53
Jan 2019
1643
134
60
Feb 2019
1781
113
57
Mar 2019
2003
125
67
Apr 2019
1933
120
41
May 2019
1187
94
24
Jun 2019
801
46
39
Jul 2019
785
37
17
Aug 2019
831
34
10
Sep 2019
1013
62
27
Oct 2019
1337
144
35
Nov 2019
1363
88
28
Dec 2019
1168
60
30
Jan 2020
1229
62
29
Feb 2020
733
55
13
Mar 2020
724
35
16
Apr 2020
963
31
30
May 2020
605
25
22
Jun 2020
562
20
9
Jul 2020
378
15
11
Aug 2020
380
20
13
Sep 2020
510
42
19
Oct 2020
980
49
33
Nov 2020
1035
44
32
Dec 2020
648
44
33
Jan 2021
558
25
19
Feb 2021
739
26
35
Mar 2021
689
24
38
Apr 2021
757
31
28
May 2021
232
19
13
Jun 2021
63
16
9
Jul 2021
65
19
6
Aug 2021
42
12
5
Sep 2021
75
28
10
Oct 2021
747
32
13
Nov 2021
690
38
15
Dec 2021
412
33
15
Jan 2022
416
28
14
Feb 2022
510
16
17
Mar 2022
472
30
7
Apr 2022
415
21
5
May 2022
454
14
10
Jun 2022
306
15
4
Jul 2022
249
14
8
Aug 2022
348
12
9
Sep 2022
248
18
11
Oct 2022
393
24
7
Nov 2022
433
35
18
Dec 2022
308
10
7
Jan 2023
341
20
12
Feb 2023
276
10
14
Mar 2023
273
11
7
Apr 2023
231
12
7
May 2023
328
14
2
Jun 2023
209
5
2
Jul 2023
165
9
1
Aug 2023
185
9
6
Sep 2023
215
9
3
Oct 2023
464
16
2
Nov 2023
660
17
7
Dec 2023
316
9
9
Jan 2024
799
9
39
Feb 2024
244
4
20
Mar 2024
302
16
8
Apr 2024
303
9
5
May 2024
403
3
5
Jun 2024
166
3
2
Jul 2024
145
7
3
Aug 2024
110
2
2
Sep 2024
166
4
6
Oct 2024
289
9
2
Nov 2024
285
3
1
Dec 2024
298
12
6
Jan 2025
135
8
4
Feb 2025
85
8
6
Mar 2025
19
1
2
Apr 2025
28
4
4
Total
49893
3187
1598
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via CCMG
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?